Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Adverio Pharma GmbH et al v. MSN Laboratories Private Limited et al
Case Number:
1:20-cv-01617
Court:
Nature of Suit:
Patent - Abbreviated New Drug Application(ANDA)
Judge:
Firms
Companies
Sectors & Industries:
-
December 18, 2020
Bayer, MSN Labs Seek To Drop Drug IP Fight Midtrial
Three days into a virtual bench trial in Delaware federal court, Bayer AG and MSN Laboratories on Friday proposed to end their legal fight over MSN's plans to market a generic version of one of Bayer's bestselling drugs, the high blood pressure medication Adempas.
-
November 30, 2020
Bayer Hits Generic Co. With Another Hypertension Drug Suit
Bayer is going to court again to stop a rival from coming out with a generic version of one of its bestselling drugs, a high blood pressure medication called Adempas.